CollPlant Biotechnologies Ltd.

NasdaqGM:CLGN 주식 보고서

시가총액: US$56.9m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

CollPlant Biotechnologies 관리

관리 기준 확인 3/4

CollPlant Biotechnologies' CEO는 Yehiel Tal, Jan2010 에 임명되었습니다 의 임기는 14.42 년입니다. 총 연간 보상은 $ 1.08M, 50.3% 로 구성됩니다. 50.3% 급여 및 49.7% 보너스(회사 주식 및 옵션 포함). 는 $ 158.80K 가치에 해당하는 회사 주식의 0.27% 직접 소유합니다. 158.80K. 경영진과 이사회의 평균 재임 기간은 각각 7.8 년과 4.8 년입니다.

주요 정보

Yehiel Tal

최고 경영자

US$1.1m

총 보상

CEO 급여 비율50.3%
CEO 임기14.5yrs
CEO 소유권0.3%
경영진 평균 재임 기간7.9yrs
이사회 평균 재임 기간4.9yrs

최근 관리 업데이트

Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Jul 29
Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Recent updates

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Feb 03
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

Nov 02
Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Sep 06
CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Jul 14
Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

Nov 10
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

CollPlant Non-GAAP EPS of -$0.36, revenue of $0.07M

Aug 25

We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

Jul 22
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 22
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company

Aug 05

Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Jul 29
Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

Jun 09
The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

CEO 보상 분석

Yehiel Tal 의 보수는 CollPlant Biotechnologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$1mUS$541k

-US$7m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$1mUS$689k

-US$17m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$14m

Dec 31 2021US$1mUS$422k

US$237k

Sep 30 2021n/an/a

US$1m

Jun 30 2021n/an/a

US$5m

Mar 31 2021n/an/a

US$6m

Dec 31 2020US$761kUS$391k

-US$6m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$11m

Mar 31 2020n/an/a

-US$11m

Dec 31 2019US$784kUS$395k

-US$11m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018n/an/a

-US$6m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$441kUS$247k

-US$6m

보상 대 시장: Yehiel 의 총 보상 ($USD 1.08M )은 US 시장( $USD 683.56K ).

보상과 수익: Yehiel 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Yehiel Tal (72 yo)

14.5yrs

테뉴어

US$1,076,000

보상

Mr. Yehiel Tal has been the Chief Executive Officer of CollPlant Biotechnologies Ltd. (formerly known as CollPlant Holdings Ltd.) since January 2010 and also serves as its Director since May 2022. Mr. Tal...

리더십 팀

이름위치테뉴어보상소유권
Yehiel Tal
CEO & Director14.5yrsUS$1.08m0.27%
$ 154.7k
Eran Rotem
Deputy CEO & CFO12.5yrsUS$748.00k데이터 없음
Oren Fahimipoor
Vice President of Operations1.3yrsUS$323.00k데이터 없음
Elana Gazal
Vice President of Research & Development1.7yrsUS$379.00k데이터 없음
Oded Shoseyov
Founder & Chief Scientist20.5yrsUS$252.97k데이터 없음
Hadas Horowitz
Vice President of Human Resources3.3yrs데이터 없음데이터 없음

7.9yrs

평균 재임 기간

52.5yo

평균 연령

경험이 풍부한 관리: CLGN 의 관리팀은 노련하고 경험 (평균 재직 기간 7.8 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Yehiel Tal
CEO & Director2.2yrsUS$1.08m0.27%
$ 154.7k
Abraham Havron
Independent Director8.2yrs데이터 없음데이터 없음
Elan Penn
Independent Director6.5yrs데이터 없음데이터 없음
Avram Hershko
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Roger Pomerantz
Independent Chairman of the Board4.4yrs데이터 없음데이터 없음
Joseph Lane
Member of the Scientific Advisory Board & Member of the Clinical Advisory Boardno data데이터 없음데이터 없음
Hugh Evans
Independent Director3.3yrs데이터 없음3.3%
$ 1.9m
Vicki Rosen
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Abhay Pandit
Member of the Scientific Advisory Boardno data데이터 없음데이터 없음
Ofer Levy
Member of the Scientific Advisory Board & Member of the Clinical Advisory Boardno data데이터 없음데이터 없음
Joseph Zarzewsky
Independent Director4.9yrs데이터 없음데이터 없음
Shay Soker
Member of Advisory Board6.1yrs데이터 없음데이터 없음

4.9yrs

평균 재임 기간

72yo

평균 연령

경험이 풍부한 이사회: CLGN 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.